Cryptogenic partial epilepsies with anti-GM1 antibodies: A new form of immune-mediated epilepsy?

Epilepsia

Volumn 37, Issue 10, 1996, Pages 922-926

  Bartolomei, Fabrice ^a,b,c   Boucraut, José ^c   Barrié, Maryline ^a,b   Kok, Jérome ^c   Dravet, Charlotte ^b   Viallat, Danièle ^b   Bernard, Dominique ^c   Gastaut, Jean Louis ^a,b  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b Center Saint Paul for Epilepsy   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Anti GM1 antibodies; Cryptogenic partial epilepsy; Epilepsy; Immunology

Indexed keywords

GANGLIOSIDE GM1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHILD; COMPLEX PARTIAL SEIZURE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NERVE BLOCK; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; SCREENING TEST;

EID: 0029811215     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00527.x     Document Type: Article

References (28)

1. Eeg-Olofson O, Osterland CK, Guttman RD, et al. Immunological studies in focal epilepsy. Acta Neurol Scand 1988; 78:358-68.
2. Aarll JA. Immunological aspects of epilepsy. Brain Dev 1993;15:41-30.
3. Milhallovic LJT, Cupic D. Epileptiform activity evoked by intracerebral injection of antibrain antibodies. Brain Res 1971;32:97-124.
4. Savic VL, Jankovic D, Horvat J. Biological activity of antibrain antibodies. Immunol Lett 1979;1:3-5.
5. Karpiac SE, Graf L, Rapport MM. Antiserum to brain gangliosldes produces recurrent epileptiform activity. Science 1976;194:735-7.
6. Karpiak SE, Mahadik SP, Graf L, Rapport MM. Immunological model of epilepsy: seizures induced by antibodies to GM1 ganglloside. Epilepsia 1982;22:189-96.
7. Inzelberg R, Korczyn AD. Lupus anticoagulant and late onset seizures. Acta Neurol Scand 1989;79:114-8.
8. Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hugues GR. Association between antiphospholipld antibodies and epilepsy in patients with systemic lupus erythematosus. Arthrilis Rheum 1994;37:568-71.
9. More PH, Lisak RP. Systemic lupus erythematosus: Immunopathogenesis of neurological dysfunction. Semin Immunopathol 1995;17:43-60.
10. Rogers SW, Hugues TE, Heinemann SF, McNamara JO. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephailtis. Science 1994;265:648-51.
11. Twyman RE, Gahring LC, Spless J, Rogers SW. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 1995;14:755-62.
12. Sadlq SA, Thomas FP, Kilidireas K, et al. The spectrum of neurological disease associated with anti-GM1 antibodies. Neurology 1990;40:1067-72.
13. Pestronk A, Li F. Motor neuropathies and motor neuron disorders: association with antiglycolipid antibodies. Adv Neurol 1991;56:426-7.
14. Pestronk A, Adams RN, Clawson L, et al. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology 1988;38:1457-61.
15. Endo T, Scott DD, Stewart SS, Kundu SK, Marcus DM. Antibodies to glycosphingoliplds in patients with multiple sclerosis and SLE. J Immunol 1984;132:1793-7.
16. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures, Epilepsia 1981;22:489-501.
17. Commission on Classification and Terminology of the International League Against Epilepsy, Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
18. Azulay JP, Blin O, Pouget J, et al. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies. Neurology 1994;44: 429-32.
19. Adams D, Kuntzner T, Burger D, Steck A. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol 1991;32:223-30.
20. Latov N, Hays AP, Donofrio PD, et al. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology 1988;38:763-8.
21. Nitsch C, Klatzo I, Regional patterns of blood-barrier break-down during epileptiform seizures induced by various convulsive agents. J Neurol Sci 1983;59:305-22.
22. Van Egelen BGM, Renler WO, Weemaes CMR, Strengers PFW, Bernsen PJH, Notermans SLH. High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Oastaut syndrome, an add on study. Eur J Pedtair 1994;153:762-9.
23. Corbo M, Quattrini A, Latov N, Hays AP, Localization of GM1 and Gal(β1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 1993;43:804-14.
24. Waxman SG. Sodium channel blockade by antibodies: a new mechanism of neuronal disease? Ann Neurol 1995;37:421-3.
25. Takigawa T, Yasuda H, Kikkawa R, Shigeta Y, Saida T, Kitasato H. Antibodies against GM1 ganglioside affect K + and Na+ current in Isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-42.
26. Vassilev PM, Scheuer T, Catterall WA. Identification of an intracellular peptide segment involved in sodium channel inactivation. Science 1988;241:1658-61.
27. Dichter M, Ayala GF. Cellular mechanisms of epilepsy, a status report. Science 1987;237:157-64.
28. Frieder B, Rapport MM. Enhancement of depolarization-induced release of g-aminobutyric acid from brain slices by antibodies to ganglioside. J Neurochem 1981;3:634-9.